• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epidemiological investigation of an outbreak of meningococcal meningitis in Makkah (Mecca), Saudi Arabia, 1992.1992年沙特阿拉伯麦加流行性脑脊髓膜炎暴发的流行病学调查
Epidemiol Infect. 1995 Dec;115(3):399-409. doi: 10.1017/s0950268800058556.
2
Meningococcal meningitis group A: a successful control of an outbreak by mass vaccination.A群脑膜炎球菌性脑膜炎:通过大规模疫苗接种成功控制疫情
East Afr Med J. 1995 Nov;72(11):715-8.
3
Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011.实验室确诊的侵袭性脑膜炎奈瑟菌病:1995 年至 2011 年沙特阿拉伯朝觐疫苗接种政策的影响。
Euro Surveill. 2013 Sep 12;18(37):20581. doi: 10.2807/1560-7917.es2013.18.37.20581.
4
[An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].[1997年多哥萨瓦内地区的脑膜炎球菌性脑膜炎疫情:研究与控制策略]
Sante. 1997 Nov-Dec;7(6):384-90.
5
Changes in epidemiological pattern of Meningococcal disease in Saudi Arabia. Does it constitute a new challenge for prevention and control?沙特阿拉伯脑膜炎球菌病流行病学模式的变化。这是否对预防和控制构成新的挑战?
Saudi Med J. 2004 Oct;25(10):1410-3.
6
Uncommon mixed outbreak of pneumococcal and meningococcal meningitis in Jirapa District, Upper West Region, Ghana, 2016.2016年,加纳上西部地区吉拉帕区发生肺炎球菌性脑膜炎和脑膜炎球菌性脑膜炎罕见混合疫情。
Ghana Med J. 2017 Dec;51(4):149-155.
7
Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.巴西里约热内卢B群脑膜炎球菌疫苗直接有效性评估:一项病例对照研究。
Int J Epidemiol. 1995 Oct;24(5):1050-7. doi: 10.1093/ije/24.5.1050.
8
Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.加纳针对流行性脑膜炎的应急疫苗接种:对西非脑膜炎球菌病控制的影响
Lancet. 2000 Jan 1;355(9197):30-3. doi: 10.1016/S0140-6736(99)03366-8.
9
Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria.通过大规模疫苗接种控制流行性脑膜炎球菌性脑膜炎。I. 尼日利亚北部A群和C群疫苗的进一步流行病学评估。
J Infect. 1984 Sep;9(2):190-6. doi: 10.1016/s0163-4453(84)91429-4.
10
Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy.意大利托斯卡纳地区 C 群/cc11 脑膜炎奈瑟菌引起的侵袭性脑膜炎球菌病爆发前后 C 群结合疫苗的有效性。
Vaccine. 2018 Jul 5;36(29):4222-4227. doi: 10.1016/j.vaccine.2018.06.002. Epub 2018 Jun 9.

引用本文的文献

1
Sacred journeys and pilgrimages: health risks associated with travels for religious purposes.神圣之旅与朝圣:宗教目的旅行相关的健康风险。
J Travel Med. 2024 Dec 10;31(8). doi: 10.1093/jtm/taae122.
2
Meningococcal Disease and Immunization Activities in Hajj and Umrah Pilgrimage: a review.朝觐和副朝朝圣中的脑膜炎球菌病及免疫活动:一项综述
Infect Dis Ther. 2022 Aug;11(4):1343-1369. doi: 10.1007/s40121-022-00620-0. Epub 2022 May 19.
3
The Epidemiology of Invasive Meningococcal Disease in the Kingdom of Saudi Arabia: A Narrative Review with Updated Analysis.沙特阿拉伯王国侵袭性脑膜炎球菌病的流行病学:一项更新分析的叙述性综述
Infect Dis Ther. 2021 Dec;10(4):2035-2049. doi: 10.1007/s40121-021-00467-x. Epub 2021 Aug 14.
4
The Emergence, Persistence, and Dissemination of Antimicrobial-Resistant Bacteria in Environmental Hajj Settings and Implications for Public Health.朝觐环境中抗菌药物耐药菌的出现、持续存在及传播及其对公共卫生的影响
Trop Med Infect Dis. 2021 Mar 10;6(1):33. doi: 10.3390/tropicalmed6010033.
5
Linking human behaviors and infectious diseases.将人类行为与传染病联系起来。
Proc Natl Acad Sci U S A. 2021 Mar 16;118(11). doi: 10.1073/pnas.2101345118.
6
A Comprehensive Review of Meningococcal Disease Burden in India.印度脑膜炎球菌病负担的综合综述
Infect Dis Ther. 2020 Sep;9(3):537-559. doi: 10.1007/s40121-020-00323-4. Epub 2020 Jul 23.
7
Serogroup A meningococcal conjugate vaccines: building sustainable and equitable vaccine strategies.A 群脑膜炎球菌结合疫苗:构建可持续和公平的疫苗策略。
Expert Rev Vaccines. 2020 May;19(5):455-463. doi: 10.1080/14760584.2020.1760097. Epub 2020 Apr 29.
8
The Hajj 2019 Vaccine Requirements and Possible New Challenges.2019 年朝觐疫苗接种要求和可能出现的新挑战。
J Epidemiol Glob Health. 2019 Sep;9(3):147-152. doi: 10.2991/jegh.k.190705.001.
9
Incidence and Prevention of Invasive Meningococcal Disease in Global Mass Gathering Events.全球大型聚集活动中侵袭性脑膜炎球菌病的发病率及预防
Infect Dis Ther. 2019 Dec;8(4):569-579. doi: 10.1007/s40121-019-00262-9. Epub 2019 Aug 30.
10
Outbreaks of meningococcal meningitis in non-African countries over the last 50 years: a systematic review.50 年来非非洲国家的脑膜炎奈瑟菌脑膜炎爆发:系统评价。
J Glob Health. 2019 Jun;9(1):010411. doi: 10.7189/jogh.09.010411.

本文引用的文献

1
Reply: Meningitis in children in Elmadina ElMunowara.
Ann Saudi Med. 1992 May;12(3):321-2. doi: 10.5144/0256-4947.1992.321a.
2
Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy.马里巴马科的脑膜炎球菌性脑膜炎疫情:流行病学特征及疫苗效力分析
Lancet. 1982 Aug 7;2(8293):315-8. doi: 10.1016/s0140-6736(82)90282-3.
3
Control of epidemic group A meningococcal meningitis in Nepal.
Int J Epidemiol. 1987 Mar;16(1):91-7. doi: 10.1093/ije/16.1.91.
4
Group A meningococcal carriage in travelers returning from Saudi Arabia.从沙特阿拉伯返回的旅行者中A群脑膜炎球菌携带情况。
JAMA. 1988 Nov 11;260(18):2686-9.
5
Epidemic group A meningococcal disease in Haj pilgrims.
Lancet. 1987 Oct 10;2(8563):863. doi: 10.1016/s0140-6736(87)91056-7.
6
Intercontinental spread of an epidemic group A Neisseria meningitidis strain.流行性A群脑膜炎奈瑟菌菌株的洲际传播
Lancet. 1989 Jul 29;2(8657):260-3. doi: 10.1016/s0140-6736(89)90439-x.
7
Features of a large epidemic of group A meningococcal meningitis in Khartoum, Sudan in 1988.1988年苏丹喀土穆A群脑膜炎球菌性脑膜炎大流行的特征
Scand J Infect Dis. 1990;22(2):161-70. doi: 10.3109/00365549009037897.

1992年沙特阿拉伯麦加流行性脑脊髓膜炎暴发的流行病学调查

Epidemiological investigation of an outbreak of meningococcal meningitis in Makkah (Mecca), Saudi Arabia, 1992.

作者信息

al-Gahtani Y M, el Bushra H E, al-Qarawi S M, al-Zubaidi A A, Fontaine R E

机构信息

Department of Preventive Medicine, Ministry of Health, Riyadh, Saudi Arabia.

出版信息

Epidemiol Infect. 1995 Dec;115(3):399-409. doi: 10.1017/s0950268800058556.

DOI:10.1017/s0950268800058556
PMID:8557071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2271597/
Abstract

During March and April of 1992, the health surveillance system began detecting increasing numbers of cases of meningococcal disease (MCD) in the Islamic holy city of Makkah (Mecca). We identified 102 bacteriologically confirmed cases (CC) and 80 suspected cases (SC) of MCD. Neisseria meningitidis was identified as Group A, III-1 clone. The ratio of male:female cases was 2.9:1. All age groups of males were affected. There was only one case among women aged 10-30; 50% of the adult female cases were 55 or older. The case-fatality ratio (CFR) was 14.7% among CC. Pakistanis, who comprised about one-third of the CC, had a CFR of 26.7%. Fifty-nine percent of CC were religious visitors. CC in residents were most common in persons living near the Holy Mosque (Haram), where the carriage rate reached 86%. A mass vaccination program against MCD was instituted, using AC bivalent meningococcal vaccine (MCV). An abrupt drop, from a mean of 15 CC per week to 2 CC per week (only in visitors), coincided with vaccinating 600,000 persons over 2 weeks. Makkah residents who had been vaccinated against MCD were less likely to have contracted MCD (OR = 0.17, 95% CI: 0.06-0.50). MCV was of no significant protective value if it had been administered 5 years before the outbreak. The main reason for not being vaccinated as stated by both cases (71%) and controls (45%) was not knowing about the disease. The age and sex differences probably relate to differences in exposures to crowded conditions. Health education should illuminate the seriousness of the disease and the importance of vaccination.

摘要

1992年3月和4月期间,健康监测系统开始发现伊斯兰教圣城麦加的脑膜炎球菌病(MCD)病例数不断增加。我们确定了102例经细菌学确诊的病例(CC)和80例疑似病例(SC)。脑膜炎奈瑟菌被鉴定为A群,III-1克隆。病例的男女比例为2.9:1。所有年龄组的男性均受影响。10至30岁的女性中仅有1例;成年女性病例的50%为55岁及以上。确诊病例的病死率(CFR)为14.7%。占确诊病例约三分之一的巴基斯坦人的病死率为26.7%。59%的确诊病例是宗教朝圣者。居民中的确诊病例在居住在圣寺(禁寺)附近的人群中最为常见,那里的带菌率达到86%。针对MCD开展了大规模疫苗接种计划,使用AC二价脑膜炎球菌疫苗(MCV)。在两周内为60万人接种疫苗的同时,每周确诊病例数从平均15例骤降至2例(仅在朝圣者中)。接种过MCD疫苗的麦加居民感染MCD的可能性较小(比值比=0.17,95%置信区间:0.06-0.50)。如果在疫情爆发前5年接种MCV,则没有显著的保护作用。病例组(71%)和对照组(45%)表示未接种疫苗的主要原因是不了解该疾病。年龄和性别差异可能与接触拥挤环境的差异有关。健康教育应阐明该疾病的严重性和疫苗接种的重要性。